Faeth Therapeutics

San Francisco, United States

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

$25.0M raised

Oct 2025

Series A

Biotechnology Health Care Medical Therapeutics

Top Investors

B CapitalKhosla VenturesS2G InvestmentsKdT VenturesDigitalis Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Faeth Therapeutics

How much funding has Faeth Therapeutics raised?

Faeth Therapeutics has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in October 2025.

Who are Faeth Therapeutics's investors?

Faeth Therapeutics's investors include B Capital, Khosla Ventures, S2G Investments, KdT Ventures, Digitalis Ventures.

Where is Faeth Therapeutics headquartered?

Faeth Therapeutics is headquartered in San Francisco, United States.

What does Faeth Therapeutics do?

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

What stage is Faeth Therapeutics at?

Faeth Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 20, 2025.

MLA

"Faeth Therapeutics — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/faeth-therapeutics. Accessed June 4, 2026.

APA

VCBacked. (2025). Faeth Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/faeth-therapeutics

Wikipedia (cite web)

{{cite web |title=Faeth Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/faeth-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 20, 2025.

Similar Companies in Biotechnology